All NIH Funding Opportunities and Notices

• NOVEL TECHNOLOGIES FOR EVALUATION OF MOLECULAR ALTERATIONS IN TISSUE - ADDENDUM
  (NOT-97-158)
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  

• MINORITY-BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
  (RFA-CA-97-016)
  National Cancer Institute
  
  

• CANCER GENETICS NETWORK - INFORMATICS AND INFORMATION TECHNOLOGY GROUP
  (RFA-CA-97-019)
  National Cancer Institute
  
  

• ACUPUNCTURE TREATMENT FOR OSTEOARTHRITIS
  (RFA-OD-97-006)
  National Center for Complementary and Alternative Medicine
  
  

• DIRECT VS INDIRECT ANTIGEN RECOGNITION IN ALLOGRAFT SURVIVAL
  (PA-97-075)
  National Institutes of Health
  
  

• IMMUNOLOGICAL ASPECTS OF HEMATOPOIETIC STEM CELLS
  (PA-97-076)
  National Institutes of Health
  
  

• MINOR HISTOCOMPATIBILITY ANTIGENS IN GVHD & GRAFT REJECTION
  (PA-97-077)
  National Institutes of Health
  
  

• INFLAMMATION IN ASTHMA AND ALLERGY
  (PA-97-078)
  National Institutes of Health
  
  

• INNATE IMMUNITY
  (PA-97-079)
  National Institute of Allergy and Infectious Diseases
  National Institute of Dental and Craniofacial Research
  
  

• BASIC AND CLINICAL RESEARCH ON IMMUNE TOLERANCE
  (PA-97-081)
  National Institutes of Health
  
  

• MANAGEMENT OF SYMPTOMS SECONDARY TO TREATMENT
  (PA-97-082)
  National Institute of Nursing Research
  National Cancer Institute
  National Institute of Mental Health
  
  

• TUBERCULOSIS - BASIC BIOLOGY, IMMUNOLOGY AND PATHOGENESIS
  (PA-97-083)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  
  

• INNOVATIVE APPROACHES TO INVESTIGATING HUMAN TUBERCULOSIS
  (PA-97-084)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  
  

• THE LATENT STATE IN TUBERCULOSIS INFECTION
  (PA-97-085)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  
  

• CHEMICAL MODIFIERS OF RADIATION RESPONSE OF TUMORS
  (PA-97-086)
  National Cancer Institute
  
  

• NOVEL HIV THERAPIES: INTEGRATED PRECLINICAL / CLINICAL PROGRAM
  (PAR-97-080)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  
  

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892